MAIA Biotechnology Inc (MAIA)
3.28
+0.16
(+5.13%)
USD |
NYAM |
May 17, 16:00
3.28
0.00 (0.00%)
After-Hours: 20:00
MAIA Biotechnology 1 Year Total Returns (Daily): 36.78% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 17, 2024 | 36.78% |
May 16, 2024 | 32.77% |
May 15, 2024 | 6.30% |
May 14, 2024 | 14.06% |
May 13, 2024 | 22.49% |
May 10, 2024 | 13.65% |
May 09, 2024 | 7.43% |
May 08, 2024 | 14.72% |
May 07, 2024 | 18.31% |
May 06, 2024 | 16.55% |
May 03, 2024 | 22.85% |
May 02, 2024 | 18.42% |
May 01, 2024 | 10.19% |
April 30, 2024 | 19.11% |
April 29, 2024 | 30.49% |
April 26, 2024 | 30.67% |
April 25, 2024 | 16.52% |
April 24, 2024 | -1.10% |
April 23, 2024 | -16.61% |
April 22, 2024 | -23.39% |
April 19, 2024 | -39.18% |
April 18, 2024 | -47.87% |
April 17, 2024 | -48.17% |
April 16, 2024 | -42.78% |
April 15, 2024 | -43.33% |
Date | Value |
---|---|
April 12, 2024 | -40.08% |
April 11, 2024 | -36.72% |
April 10, 2024 | -32.04% |
April 09, 2024 | -25.51% |
April 08, 2024 | -27.83% |
April 05, 2024 | -30.27% |
April 04, 2024 | -37.32% |
April 03, 2024 | -35.01% |
April 02, 2024 | -32.08% |
April 01, 2024 | -28.32% |
March 28, 2024 | -36.96% |
March 27, 2024 | -27.91% |
March 26, 2024 | -31.07% |
March 25, 2024 | -27.97% |
March 22, 2024 | -31.05% |
March 21, 2024 | -36.60% |
March 20, 2024 | -48.11% |
March 19, 2024 | -48.48% |
March 18, 2024 | -54.27% |
March 15, 2024 | -62.63% |
March 14, 2024 | -66.58% |
March 13, 2024 | -64.64% |
March 12, 2024 | -67.25% |
March 11, 2024 | -67.55% |
March 08, 2024 | -67.56% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-75.61%
Minimum
Dec 04 2023
36.78%
Maximum
May 17 2024
-48.60%
Average
-55.94%
Median
1 Year Total Returns (Daily) Benchmarks
Cyclacel Pharmaceuticals Inc | -76.51% |
Avid Bioservices Inc | -40.04% |
Oragenics Inc | -21.02% |
NeuBase Therapeutics Inc | -90.25% |
Viking Therapeutics Inc | 174.5% |